Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pruneri

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
International Journal of Surgical Pathology|October 2, 2009
Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?D Laszlo, G Pruneri, G Andreola, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
The American Journal of Pathology|May 4, 2000
Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)G Pruneri, S Fabris, L Baldini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breastS Di Cosimo, V Appierto, M Silvestri, et al.
Ecancermedicalscience|January 26, 2012
Resection of colorectal liver metastases following neoadjuvant chemotherapyA Chiappa, E Bertani, R Biffi, et al.
Anticancer Research|July 25, 1998
Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progressionF Guddo, A Giatromanolaki, C Patriarca, et al.
British Journal of Cancer|February 13, 2014
Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoidsF Toffalorio, E Belloni, M Barberis, et al.
Ecancermedicalscience|January 26, 2012
Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphomaE Cocorocchio, A Vanazzi, S Bassi, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
International Journal of Surgical Pathology|October 2, 2009
Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?D Laszlo, G Pruneri, G Andreola, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
The American Journal of Pathology|May 4, 2000
Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)G Pruneri, S Fabris, L Baldini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breastS Di Cosimo, V Appierto, M Silvestri, et al.
Ecancermedicalscience|January 26, 2012
Resection of colorectal liver metastases following neoadjuvant chemotherapyA Chiappa, E Bertani, R Biffi, et al.
Anticancer Research|July 25, 1998
Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progressionF Guddo, A Giatromanolaki, C Patriarca, et al.
British Journal of Cancer|February 13, 2014
Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoidsF Toffalorio, E Belloni, M Barberis, et al.
Ecancermedicalscience|January 26, 2012
Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphomaE Cocorocchio, A Vanazzi, S Bassi, et al.
Pageof 11